Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Information Disclosure Statement
The information disclosure statement (IDS) submitted on 1/28/2026 was filed after the mailing date of the application on 4/16/2025. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner.
The information disclosure statement (IDS) submitted on 8/15/2025 was filed after the mailing date of the application on 4/16/2025. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claim(s) 16-35 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Greene (US Patent Publication 20230277857).
As per claims 16, 29 and 35: Greene discloses a method comprising:
establishing, by processing circuitry of a medical device, a secure communications channel over a wireless connection with an external device (Paragraph 72; FIG. 6 illustrates, by way of example and not limitation, the remote programming system of FIG. 5 in which exchanged messages between the clinician programmer and the implantable medical device are only understood by the clinician programmer and the implantable medical device);
negotiating, by the processing circuitry with the external device via the secure communications channel, one or more encryption keys for secure communication between the medical device and the external device (Paragraph 72; the exchanged messages between the medical device 601 and the clinician programmer 603 are only understood by the medical device 601 and the clinician programmer 603 using one or more secret key(s) established during a pairing sequence); and
encrypting, by the processing circuitry, communications with the external device using the one or more encryption keys (Paragraph 72; That is, only the clinician programmer 603 and the medical device 601 have the encryption key(s) required to decrypt the encrypted messages transmitted between the medical device 601 to the clinician programmer 603).
As per claim 17: The method of claim 16, wherein establishing the secure communications channel over the wireless connection with the external device further comprises:
establishing, by the processing circuitry, a Transport Layer Security (TLS) tunnel over the wireless connection with the external device (paragraph 72; . TLS, or other state of the art technique for securing Internet communication, may be used to secure the communication between the user device 602 and the clinician programmer 603).
As per claims 18 and 30: The method of claim 16, wherein negotiating the one or more encryption keys further comprises:
generating, by the processing circuitry, the one or more encryption keys (paragraph 70; generated session keys can then be used to provide the encrypted communication);
encrypting, by the processing circuitry, the one or more encryption keys using a session key associated with the secure communications channel (paragraph 70; Encryption key(s) are established on the ends (e.g., “applications”) of intended communication channel so that only the applications operating on devices with the encryption key(s) are able to encrypt and decrypt the messages); and
sending, by the processing circuitry via the wireless connection to the external device, the encrypted one or more encryption keys (paragraph 70; A handshake process may be used to initiate secure communication between devices).
As per claims 19 and 31: The method of claim 16, wherein negotiating the one or more encryption keys further comprises:
receiving, by the processing circuitry via the wireless connection from the external device, the one or more encryption keys that are encrypted using a session key associated with the secure communications channel (Paragraph 71; creates two secure communication channels. The illustrated first secure communication channel 514A and 514B, created using a first security protocol, extends between the clinician programmer 503 and the user device 502, and passes through server(s) within the cloud 504); and
decrypting, by the processing circuitry, the one or more encryption keys using the session key associated with the secure communications channel (paragraph 72; only the clinician programmer 603 and the medical device 601 have the encryption key(s) required to decrypt the encrypted messages transmitted between the medical device 601 to the clinician programmer 603).
As per claims 20 and 32: The method of claim 16, further comprising:
receiving, by the processing circuitry via the wireless connection, validation information
associated with the external device;
determining, by the processing circuitry and based at least in part on the validation information, whether the external device is authorized to establish a communication link with the medical device (paragraph 70; Both parties at the end of a communication link may be required to prove its identity before a connection can be made. Thus, digital certificates may be used to authenticate each device, including the intermediate device(s) in the cloud, used to transmit the communication); and
in response to determining that the external device is authorized to establish the
communication link with the medical device, establishing, by the processing circuitry, the secure communications channel over the wireless connection with the external device (Paragraph 70; When a certificate-providing device provides its digital certificate, another device can verify the certificate with the certificate authority that issued it to confirm that the certificate-providing device is who it says it is. Encryption involves various processes to ensure the messages are unreadable in transit between network nodes for the purpose of providing data security over a shared communication channel).
As per claims 21 and 33: The method of claim 16, wherein encrypting the communications via the wireless connection with the external device using the one or more encryption keys further comprises:
encrypting, by the processing circuitry, the communications over at least one of: a link layer of the wireless connection or an application layer of the wireless connection with the external device using the one or more encryption keys (Paragraph 72; That is, only the clinician programmer 603 and the medical device 601 have the encryption key(s) required to decrypt the encrypted messages transmitted between the medical device 601 to the clinician programmer 603).
As per claims 22 and 34: The method of claim 16, further comprising:
determining, by the processing circuitry, that one or more signals of sensing circuitry are indicative of an occurrence of a physical user interaction with the medical device (paragraph 70; Both parties at the end of a communication link may be required to prove its identity before a connection can be made. Thus, digital certificates may be used to authenticate each device, including the intermediate device(s) in the cloud, used to transmit the communication); and
in response to determining that the one or more signals are indicative of the occurrence of the physical user interaction, updating, by the processing circuitry, how often the medical device broadcasts one or more advertisements that indicate the medical device is able to be paired with other external devices (Paragraph 70; When a certificate-providing device provides its digital certificate, another device can verify the certificate with the certificate authority that issued it to confirm that the certificate-providing device is who it says it is. Encryption involves various processes to ensure the messages are unreadable in transit between network nodes for the purpose of providing data security over a shared communication channel).
As per claim 24: The method of claim 16, wherein encrypting the communications with the external device using the one or more encryption keys further comprises:
encrypting, by the processing circuitry, communications via a second wireless connection with the external device using the one or more encryption keys (Paragraph 72; That is, only the clinician programmer 603 and the medical device 601 have the encryption key(s) required to decrypt the encrypted messages transmitted between the medical device 601 to the clinician programmer 603).
As per claim 25: The method of claim 24, wherein the second wireless connection comprises an inductive coupling communication link (Paragraph 70; Both parties at the end of a communication link may be required to prove its identity before a connection can be made).
As per claim 26: The method of claim 16, further comprising:
encrypting, by the processing circuitry and using the one or more encryption keys, advertising payloads of advertising packets broadcasted by the medical device (paragraph 70; Encryption key(s) are established on the ends (e.g., “applications”) of intended communication channel so that only the applications operating on devices with the encryption key(s) are able to encrypt and decrypt the messages).
As per claim 27: The method of claim 26, wherein negotiating the one or more encryption keys further comprises
negotiating, by the processing circuitry with the external device via the secure communications channel, a plurality of encryption keys for secure communication between the medical device and the external device (Paragraph 72; the exchanged messages between the medical device 601 and the clinician programmer 603 are only understood by the medical device 601 and the clinician programmer 603 using one or more secret key(s) established during a pairing sequence),
wherein encrypting the communications with the external device using the one or more encryption keys further comprises encrypting, by the processing circuitry, communications with the external device using a first one or more encryption keys of the plurality of encryption keys (Paragraph 72; That is, only the clinician programmer 603 and the medical device 601 have the encryption key(s) required to decrypt the encrypted messages transmitted between the medical device 601 to the clinician programmer 603), and wherein encrypting the advertising payloads of advertising packets broadcasted by the medical device further comprises
encrypting, by the processing circuitry and using a second one or more encryption keys of the plurality of encryption keys, the advertising payloads of the advertising packets broadcasted by the medical device (Paragraph 72).
As per claim 28: The method of claim 16, wherein the wireless connection comprises a
Bluetooth Low Energy (BLE) connection (paragraph 59; Bluetooth Low Energy (BLE)).
Claim Rejections - 35 USC § 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claim 23 are rejected under 35 U.S.C. 103 as being unpatentable over Greene (US Patent Publication 2023/0277857) in view of Sheldon (US Patent Publication 2022/0323768).
As per claim 23: The method of claim 16, further comprising:
establishing, by processing circuitry of a medical device, a secure communications channel over a wireless connection with an external device (Paragraph 72; FIG. 6 illustrates, by way of example and not limitation, the remote programming system of FIG. 5 in which exchanged messages between the clinician programmer and the implantable medical device are only understood by the clinician programmer and the implantable medical device);
Greene do not specifically disclose receiving, by the processing circuitry, a tissue conductance communication (TCC) sting signal; and in response to receiving the TCC sting signal, updating, by the processing circuitry, how often the medical device broadcasts one or more advertisements that indicate the medical device is able to be paired with other external devices based at least in part on the TCC signal (See Sheldon, Paragraph 174; Control circuit 206 may receive the transmitted signal, e.g., a radio frequency signal, tissue conductance communication (TCC) signal or other transmitted signal via communication circuitry, e.g., telemetry circuit 208, as an atrial event signal for triggering a ventricular pacing pulse).
Therefore, it would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains, having the teachings of Greene and Sheldon in it’s entirety, to modify the technique of Greene for a tissue conductance communication by adopting Sheldon's teaching for tissue conductance communication (TCC) signal or other transmitted signal via communication circuitry. The motivation would have been to improve secure communications sessions between a medical device and an eternal device.
Relevant Prior Art References
The following prior art is cited as being of interest to the claimed invention but has not been applied in any of the current rejections.
Stanley et al.- US Patent Publication 2022/0361755- the prior art teaches techniques for securely exchanging information between a medical device and mobile device.
Ahmad et al.- US Patent Pub. 2018/0270340 - the prior art teaches techniques for communication system for pairing user devices with medical devices.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANTHONY D BROWN whose telephone number is (571)270-1472. The examiner can normally be reached 730-330pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Linglan Edwards can be reached at 5712705440. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/ANTHONY D BROWN/Primary Examiner, Art Unit 2408